Palliative Short Course Radiotherapy for Advanced Thoracic Cancer
NCT ID: NCT03465553
Last Updated: 2018-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2009-01-01
2018-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short Course Radiation Therapy in Palliative Treatment
NCT03196700
Short Course Radiation Therapy in Palliative Treatment of Thoracic Cancer
NCT03804307
2D-radiotherapy in Palliation of Advanced Esophageal Cancer
NCT03922152
Short Course Radiotherapy in Complicated Bone Metastases Palliation
NCT03455231
Prospecitve Observational Study on a Risk Adaptive Scheme for SBRT for Thoracic Nodes Metastases
NCT02970955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Short course radiotherapy
The radiotherapy is delivered over 2 days with accelerated hypo-fractionation.
Short course radiotherapy
An accelerated hypo-fractionation radiotherapy is delivered for palliation in patients with advanced thoracic cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Short course radiotherapy
An accelerated hypo-fractionation radiotherapy is delivered for palliation in patients with advanced thoracic cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* excluded from curative therapy because of disease stage and/or presence of multiple comorbidities and/or poor performance status
* age \> 18 years
* Eastern Cooperative Oncology Group (ECOG) \<3
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alessio Giuseppe Morganti
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessio G. Morganti, MD
Role: PRINCIPAL_INVESTIGATOR
Radiation Oncology Center, Dept. of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S.Orsola-Malpighi Hospital, Bologna, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radiation Oncology Center, Dept. of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S.Orsola-Malpighi Hospital
Bologna, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Farina E, Macchia G, Buwenge M, Siepe G, Zamagni A, Cammelli S, Cilla S, Wondemagegnhu T, Woldemariam AA, Uddin AFMK, Sumon MA, Cellini F, Deodato F, Morganti AG. Radiotherapy in palliation of thoracic tumors: a phase I-II study (SHARON project). Clin Exp Metastasis. 2018 Dec;35(8):739-746. doi: 10.1007/s10585-018-9942-6. Epub 2018 Oct 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHARON LUNG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.